ARMISTICE CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Aridis Pharmaceuticals, Inc. (ARDS)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aridis Pharmaceuticals, Inc. Common Stock
Symbol: ARDS
Shares outstanding: 44.6M shares
Disclosed Ownership: 5.1M shares
Ownership: 11.4%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 04:49 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	11.43%	5.1M	0	5.1M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	11.43%	5.1M	0	5.1M	/s/ Steven Boyd	Steven Boyd